These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33647779)

  • 1. Colorectal liver metastases: ADC as an imaging biomarker of tumor behavior and therapeutic response.
    Boraschi P; Donati F; Cervelli R; Pacciardi F; Tarantini G; Castagna M; Urbani L; Lencioni R
    Eur J Radiol; 2021 Apr; 137():109609. PubMed ID: 33647779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3T diffusion-weighted MRI in the response assessment of colorectal liver metastases after chemotherapy: Correlation between ADC value and histological tumour regression grading.
    Donati F; Boraschi P; Pacciardi F; Cervelli R; Castagna M; Urbani L; Falaschi F; Caramella D
    Eur J Radiol; 2017 Jun; 91():57-65. PubMed ID: 28629572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in apparent diffusion coefficient and pathological response in colorectal liver metastases after preoperative chemotherapy.
    Eriksson S; Bengtsson J; Torén W; Lätt J; Andersson R; Sturesson C
    Acta Radiol; 2023 Jan; 64(1):51-57. PubMed ID: 35084232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined value of apparent diffusion coefficient-standardized uptake value max in evaluation of post-treated locally advanced rectal cancer.
    Ippolito D; Fior D; Trattenero C; Ponti ED; Drago S; Guerra L; Franzesi CT; Sironi S
    World J Radiol; 2015 Dec; 7(12):509-20. PubMed ID: 26753066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization.
    Schmeel FC; Simon B; Luetkens JA; Träber F; Meyer C; Schmeel LC; Sabet A; Ezziddin S; Schild HH; Hadizadeh DR
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1531-1541. PubMed ID: 28317063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of diffusion weighted MR imaging as an early surrogate parameter for evaluation of tumor response to high-dose-rate brachytherapy of colorectal liver metastases.
    Wybranski C; Zeile M; Löwenthal D; Fischbach F; Pech M; Röhl FW; Gademann G; Ricke J; Dudeck O
    Radiat Oncol; 2011 Apr; 6(1):43. PubMed ID: 21524305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting Treatment Response of Colorectal Cancer Liver Metastases to Conventional Lipiodol-Based Transarterial Chemoembolization Using Diffusion-Weighted MR Imaging: Value of Pretreatment Apparent Diffusion Coefficients (ADC) and ADC Changes Under Therapy.
    Lahrsow M; Albrecht MH; Bickford MW; Vogl TJ
    Cardiovasc Intervent Radiol; 2017 Jun; 40(6):852-859. PubMed ID: 28357571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment response of colorectal cancer liver metastases to neoadjuvant or conversion therapy: a prospective multicentre follow-up study using MRI, diffusion-weighted imaging and
    Uutela A; Ovissi A; Hakkarainen A; Ristimäki A; Lundbom N; Kallio R; Soveri LM; Salminen T; Ålgars A; Halonen P; Ristamäki R; Nordin A; Blanco Sequeiros R; Rinta-Kiikka I; Lantto E; Virtanen J; Pääkkö E; Liukkonen E; Saunavaara J; Ryymin P; Lammentausta E; Osterlund P; Isoniemi H;
    ESMO Open; 2021 Aug; 6(4):100208. PubMed ID: 34325107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and (18) F-FDG-PET/CT: correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade.
    Giganti F; De Cobelli F; Canevari C; Orsenigo E; Gallivanone F; Esposito A; Castiglioni I; Ambrosi A; Albarello L; Mazza E; Gianolli L; Staudacher C; Del Maschio A
    J Magn Reson Imaging; 2014 Nov; 40(5):1147-57. PubMed ID: 24214734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
    Iannicelli E; Di Pietropaolo M; Pilozzi E; Osti MF; Valentino M; Masoni L; Ferri M
    Abdom Radiol (NY); 2016 Oct; 41(10):1906-17. PubMed ID: 27323759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of diffusion-weighted magnetic resonance imaging at 3.0T for early assessment of tumor response in locally advanced rectal cancer treated with preoperative chemoradiation therapy.
    Delli Pizzi A; Cianci R; Genovesi D; Esposito G; Timpani M; Tavoletta A; Pulsone P; Basilico R; Gabrielli D; Rosa C; Caravatta L; Di Tommaso M; Caulo M; Filippone A
    Abdom Radiol (NY); 2018 Sep; 43(9):2221-2230. PubMed ID: 29332248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver metastases from colorectal cancer treated with conventional and antiangiogenetic chemotherapy: evaluation with liver computed tomography perfusion and magnetic resonance diffusion-weighted imaging.
    Anzidei M; Napoli A; Zaccagna F; Cartocci G; Saba L; Menichini G; Cavallo Marincola B; Marotta E; Di Mare L; Catalano C; Passariello R
    J Comput Assist Tomogr; 2011; 35(6):690-6. PubMed ID: 22082538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apparent diffusion coefficient modifications in assessing gastro-oesophageal cancer response to neoadjuvant treatment: comparison with tumour regression grade at histology.
    De Cobelli F; Giganti F; Orsenigo E; Cellina M; Esposito A; Agostini G; Albarello L; Mazza E; Ambrosi A; Socci C; Staudacher C; Del Maschio A
    Eur Radiol; 2013 Aug; 23(8):2165-74. PubMed ID: 23588582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the residual tumour of colorectal liver metastases after chemotherapy: diffusion-weighted MR magnetic resonance imaging in the peripheral and entire tumour.
    Wagner M; Ronot M; Doblas S; Giraudeau C; Van Beers B; Belghiti J; Paradis V; Vilgrain V
    Eur Radiol; 2016 Jan; 26(1):206-15. PubMed ID: 25933743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion-weighted magnetic resonance imaging in the prediction and assessment of chemotherapy outcome in liver metastases.
    Mungai F; Pasquinelli F; Mazzoni LN; Virgili G; Ragozzino A; Quaia E; Morana G; Giovagnoni A; Grazioli L; Colagrande S
    Radiol Med; 2014 Aug; 119(8):625-33. PubMed ID: 24408046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of MR histogram analyses for prediction of response to chemotherapy in patients with colorectal hepatic metastases.
    Liang HY; Huang YQ; Yang ZX; Ying-Ding ; Zeng MS; Rao SX
    Eur Radiol; 2016 Jul; 26(7):2009-18. PubMed ID: 26494642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep learning-assisted magnetic resonance imaging prediction of tumor response to chemotherapy in patients with colorectal liver metastases.
    Zhu HB; Xu D; Ye M; Sun L; Zhang XY; Li XT; Nie P; Xing BC; Sun YS
    Int J Cancer; 2021 Apr; 148(7):1717-1730. PubMed ID: 33284998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion-weighted magnetic resonance for prediction of response after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: preliminary results of a monoinstitutional prospective study.
    Genovesi D; Filippone A; Ausili Cèfaro G; Trignani M; Vinciguerra A; Augurio A; Di Tommaso M; Borzillo V; Sabatino F; Innocenti P; Liberatore E; Colecchia G; Tartaro A; Cotroneo AR
    Eur J Surg Oncol; 2013 Oct; 39(10):1071-8. PubMed ID: 23953231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equivalent cross-relaxation rate imaging and diffusion weighted imaging for early prediction of response to bevacizumab-containing treatment in colorectal liver metastases-preliminary study.
    Matsushima S; Sato T; Nishiofuku H; Sato Y; Murata S; Kinosada Y; Era S; Inaba Y
    Clin Imaging; 2017; 41():1-6. PubMed ID: 27721090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and Viability of Colorectal Liver Metastases After Neoadjuvant Chemotherapy: A Multiparametric PET/CT-MRI Study.
    Dunet V; Halkic N; Prior JO; Anaye A; Meuli RA; Sempoux C; Denys A; Schmidt S
    Clin Nucl Med; 2017 Apr; 42(4):258-263. PubMed ID: 28166142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.